NURIX THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 8397000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-02-28) |
| Status | current |
| Entity | NURIX THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:43:23.910780+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0738e298-4b21-4fb7-a2c6-dd9294cd3f7a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001549595-25-000055 · Open the official SEC filing →Retrieved: 2026-08-19T15:43:23.910780+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001549595/accounts-payable/2025-02-28 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0738e298-4b21-4fb7-a2c6-dd9294cd3f7a
History
- no predecessors — first report